Sebia USA Email Format

Medical Equipment ManufacturingGeorgia, United States51-200 Employees

Sebia USA, based in Norcross, Georgia, provides in vitro diagnostic instruments and reagents for screening and monitoring diseases across oncology, diabetes, hemoglobinopathies, autoimmune and infectious diseases, and other rare disorders. Its capillary electrophoresis lineup, led by CAPILLARYS 3, features automated, multi-assay systems designed for high-throughput walkaway operation. In autoimmune and infectious disease testing, the company supplies ELISA and IFA solutions, including automated platforms for digital imaging and interpretation, with assays such as anti-MCV and the Borrelia MTTT algorithm; some offerings are described as not FDA approved.

The company serves clinical laboratories and diagnostic centers seeking efficient, high-volume workflows that reduce manual intervention and improve traceability. In 2024, Sebia Group expanded its offices in the United States, signaling ongoing regional growth.

Sign up for free to view info

Company overview Employee directory